JorgeAlbertoMarreroMDMS
Gastroenterology • Philadelphia, PAHepatology & Liver Transplantation
Professor, Internal Medicine, University of Pennsylvania Perelman School of Medicine
Dr. Marrero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
PCAM South Pavilion 713
Philadelphia, PA 19104Phone+1 215-614-1929
Education & Training
- The University of Texas at DallasMS, Master of Science in Healthcare Leadership and Management, 2015 - 2017
- University of MichiganMS, Clinical Research Design and Statistical Analysis, 2001 - 2003
- University of Illinois College of Medicine at ChicagoFellowship, Gastroenterology, 1996 - 1999
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1993 - 1996
- Ponce Health Sciences University School of MedicineClass of 1993
Certifications & Licensure
PA State Medical License 1995 - 2026
TX State Medical License 2012 - 2021
MI State Medical License 2000 - 2013
IL State Medical License 1996 - 2002
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 1 citationsPhase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis.Naoto Fujiwara, Camden Lopez, Tracey L Marsh, Indu Raman, Cesia A Marquez
Gastroenterology. 2025-03-01 - 4 citationsA Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis.Tracey L Marsh, Neehar D Parikh, Lewis R Roberts, Myron E Schwartz, Mindie H Nguyen
Gastroenterology. 2025-02-01 - 2 citationsHES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States.Hashem B El-Serag, Qingchun Jin, Nabihah Tayob, Emad Salem, Michelle Luster
Hepatology. 2025-02-01
Press Mentions
An Unprecedented Year Sees Unprecedented Expansion in Physician Leadership at Penn MedicineDecember 16th, 2021
Grant Support
- Clinical Validation Center for Hepatocellular CarcinomaUT SOUTHWESTERN MEDICAL CENTER2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
